Myr-TAT-CBD3

Myr-TAT-CBD3

• UNSPSC Description: Myr-TAT-CBD3 is CRMP2-CaV2.2 interaction inhibitor. Myr-tat-CBD3 can significantly attenuate carrageenan-induced thermal hypersensitivity and reverse thermal hypersensitivity induced in a rat model of postoperative pain. Myr-TAT-CBD3 can be used to study inflammation and postoperative pain[1].
• Target Antigen: Calcium Channel
• Type: Peptides
• Related Pathways: Membrane Transporter/Ion Channel;Neuronal Signaling
• Applications: COVID-19-immunoregulation
• Field of Research: Inflammation/Immunology
• Assay Protocol: https://www.medchemexpress.com/myr-tat-cbd3.html
• Solubility: 10 mM in DMSO
• Smiles: CCCCCCCCCCCCCC(N[C@H](C(NCC(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](C)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@@H](C)C(N[C@H](C(N[C@@H](CC(C)C)C(N[C@H](C(NCC(N[C@H](C(N1CCC[C@H]1C(N[C@H](C(NCC(N[C@@H](CC(C)C)C(O)=O)=O)=O)CCCNC(N)=N)=O)=O)C(C)C)=O)=O)CCCNC(N)=N)=O)=O)CCC(O)=O)=O)=O)=O)CCCNC(N)=N)=O)CO)=O)CCCNC(N)=N)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCC(N)=O)=O)CCCNC(N)=N)=O)CCCNC(N)=N)=O)CCCCN[H])=O)CCCCN[H])=O)CCCNC(N)=N)=O)=O)CC2=CC=C(C=C2)O)=O
• Molecular Weight: 3403.09
• References & Citations: [1]François-Moutal L, et al. A membrane-delimited N-myristoylated CRMP2 peptide aptamer inhibits CaV2.2 trafficking and reverses inflammatory and postoperative pain behaviors. Pain. 2015 Jul;156(7):1247-1264.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported